ProCE Banner Activity

GIP/GLP-1 Coagonists, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: A Quick Reference Guide

PDF

Download this infographic to use as a quick reference in selecting the most appropriate type 2 diabetes treatments for your patients.

Released: November 09, 2023

Share

Faculty

Vivian A. Fonseca

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

Provided by

Provided by Clinical Care Options, LLC in partnership with the Endocrine Society.

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Endocrine Society

ProCE Banner

Disclosure

Primary Author

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

Vivian Fonseca, MD, FRCP: researcher (paid to institution): Fractyl, Jaguar Gene Therapy; consultant/advisor/speaker: Abbott, Asahi, Bayer, Boehringer Ingelheim, Corcept; stock/stock options: Abbott, Amgen, BRAVO4Health, Mellitus.